Sensus Healthcare (SRTS) Free Cash Flow Growth (3y) (2020 - 2026)
Sensus Healthcare (SRTS) Free Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn | -0.27% |
| 10 | Sensus Healthcare | 49.88 Mn | 31.55 Mn | - | 15.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.03% |
| Dec 31, 2025 | 41.97% |
| Sep 30, 2025 | -16.10% |
| Jun 30, 2025 | 18.63% |
| Mar 31, 2025 | -42.33% |
| Dec 31, 2024 | 10.19% |
| Sep 30, 2024 | 47.58% |
| Jun 30, 2024 | 50.65% |
| Mar 31, 2024 | -91.71% |
| Dec 31, 2023 | 96.36% |
| Sep 30, 2023 | 29.20% |
| Jun 30, 2023 | -37.27% |
| Mar 31, 2023 | -180.43% |
| Dec 31, 2022 | -168.00% |
| Sep 30, 2022 | 57.27% |
| Jun 30, 2022 | -32.26% |
| Mar 31, 2022 | 34.37% |
| Dec 31, 2021 | -1.38% |
| Sep 30, 2021 | 35.62% |
| Jun 30, 2021 | 43.85% |